2023
DOI: 10.1001/jamanetworkopen.2023.5897
|View full text |Cite
|
Sign up to set email alerts
|

Financial Toxicity and Its Association With Health-Related Quality of Life Among Partners of Colorectal Cancer Survivors

Abstract: ImportancePartners of colorectal cancer (CRC) survivors play a critical role in diagnosis, treatment, and survivorship. While financial toxicity (FT) is well documented among patients with CRC, little is known about long-term FT and its association with health-related quality of life (HRQoL) among their partners.ObjectiveTo understand long-term FT and its association with HRQoL among partners of CRC survivors.Design, Setting, and ParticipantsThis survey study incorporating a mixed-methods design consisted of a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 16 publications
(6 citation statements)
references
References 46 publications
1
5
0
Order By: Relevance
“…The significant positive correlation between the COST and HRQoL measured using the EQ-5D or EQ VAS supports the convergent validity of the COST. This finding provides evidence that patients with higher COST scores experience higher HRQoL; consequently, a higher level of FT is associated with worse HRQoL, which is consistent with previous studies [ 7 , 30 , 31 ]. In addition, factors such as low socioeconomic status and cancer treatment bolster evidence for the multidimensionality of the FT [ 6 , 32 ] and the validity of the COST for application across diverse clinical characteristics and settings [ 7 ].…”
Section: Discussionsupporting
confidence: 92%
“…The significant positive correlation between the COST and HRQoL measured using the EQ-5D or EQ VAS supports the convergent validity of the COST. This finding provides evidence that patients with higher COST scores experience higher HRQoL; consequently, a higher level of FT is associated with worse HRQoL, which is consistent with previous studies [ 7 , 30 , 31 ]. In addition, factors such as low socioeconomic status and cancer treatment bolster evidence for the multidimensionality of the FT [ 6 , 32 ] and the validity of the COST for application across diverse clinical characteristics and settings [ 7 ].…”
Section: Discussionsupporting
confidence: 92%
“…Spouses of survivors with cancer-related health problems, medical events, or disabilities are more likely to experience worse mental and physical health-related quality of life than their counterparts whose spouses do not have cancer-related health problems. 74,75 The burden of informal caregiving falls disproportionately on women; among employed spouses, women whose spouses were receiving cancer treatment were more likely to take time off work to provide care and took more days off. 76 In addition, parental cancer history is associated with worse physical and mental health for their dependent children and more sick days missed from school.…”
Section: What Does a Cancer Diagnosis Mean For Household Financial St...mentioning
confidence: 99%
“…If they work for small employers who have fewer than 50 employees, they do not have options for job‐protected unpaid leave under the FMLA. Spouses of survivors with cancer‐related health problems, medical events, or disabilities are more likely to experience worse mental and physical health‐related quality of life than their counterparts whose spouses do not have cancer‐related health problems 74,75 . The burden of informal caregiving falls disproportionately on women; among employed spouses, women whose spouses were receiving cancer treatment were more likely to take time off work to provide care and took more days off 76 .…”
Section: What Does a Cancer Diagnosis Mean For Household Financial St...mentioning
confidence: 99%
“…Treatment with ICI is placing an increasing financial burden on patients and healthcare services worldwide, with annual costs of these treatments expected to grow from $24 billion in 2022 to $46 billion in 2026 [9]. For individual patients, the financial implications of treatment are associated with poor HRQoL [10][11][12].…”
Section: Introductionmentioning
confidence: 99%